Association Between 5-α Reductase Inhibition and Risk of Hip Fracture.
In: JAMA: Journal of the American Medical Association, Jg. 300 (2008-10-08), Heft 14, S. 1660-1664
academicJournal
Zugriff:
The article discusses the treatment of benign prostatic hyperplasia (BPH) with 5-α reductase inhibitors such as finasteride, specifically looking for a correlation between the use of the drug with increased occurrence of hip fracture. The use of 5-α reductase converts testosterone to dihydrotestosterone, the article states. The study included over 7,000 men using data from Kaiser Permanente Southern California. Topics include the possibility that dihydrotestosterone might play a role in bone metabolism and a case-control study of hip fracture among men.
Titel: |
Association Between 5-α Reductase Inhibition and Risk of Hip Fracture.
|
---|---|
Autor/in / Beteiligte Person: | .lacobsen, Steven J. ; Cheetham, T. Craig ; Haque, Reina ; Shi, Jiaxiao M. ; Loo, Ronald K. |
Zeitschrift: | JAMA: Journal of the American Medical Association, Jg. 300 (2008-10-08), Heft 14, S. 1660-1664 |
Veröffentlichung: | 2008 |
Medientyp: | academicJournal |
ISSN: | 0098-7484 (print) |
DOI: | 10.1001/jama.300.14.1660 |
Schlagwort: |
|
Sonstiges: |
|